TYLER M NIXON
Allopathic & Osteopathic Physicians|Internal Medicine LAYTON, UT NPI 1669639985
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine UT Corcept Therapeutics All categories
General Payments — all program years on this page
$183.60
- Category: General Payments
- Program years: PY2024
- Record count: 8
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $183.60 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $183.60 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Corcept Therapeutics | $59.87 | 3 |
| KVK-Tech, Inc. | $48.85 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $24.88 | 1 |
| ABBVIE INC. | $17.53 | 1 |
| Novo Nordisk AS | $16.43 | 1 |
| Lilly USA, LLC | $16.04 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2024 | $183.60 | 8 |
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1069173708 | KVK-Tech, Inc. | $48.85 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1087141166 | Novartis Pharmaceuticals Corporation | $24.88 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1096876394 | Novo Nordisk Inc | $16.43 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105129601 | ABBVIE INC. | $17.53 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117792198 | Corcept Therapeutics | $17.76 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117792216 | Corcept Therapeutics | $17.51 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117792244 | Corcept Therapeutics | $24.60 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135471875 | Lilly USA, LLC | $16.04 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.